237 related articles for article (PubMed ID: 37151889)
1. Deubiquitinase USP13 regulates glycolytic reprogramming and progression in osteosarcoma by stabilizing METTL3/m
Wang C; Meng Y; Zhao J; Ma J; Zhao Y; Gao R; Liu W; Zhou X
Int J Biol Sci; 2023; 19(7):2289-2303. PubMed ID: 37151889
[TBL] [Abstract][Full Text] [Related]
2. N
Gao Z; Li C; Sun H; Bian Y; Cui Z; Wang N; Wang Z; Yang Y; Liu Z; He Z; Li B; Li F; Li Z; Wang L; Zhang D; Yang L; Xu Z; Li X; Xu H
Cell Death Differ; 2023 Feb; 30(2):544-559. PubMed ID: 36528756
[TBL] [Abstract][Full Text] [Related]
3. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
Miao W; Chen J; Jia L; Ma J; Song D
Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
[TBL] [Abstract][Full Text] [Related]
4. USP13 deubiquitinates and stabilizes cyclin D1 to promote gastric cancer cell cycle progression and cell proliferation.
Ma C; Wang D; Tian Z; Gao W; Zang Y; Qian L; Xu X; Jia J; Liu Z
Oncogene; 2023 Jul; 42(29):2249-2262. PubMed ID: 37311811
[TBL] [Abstract][Full Text] [Related]
5. ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression.
An X; Wu W; Yang L; Dong J; Liu B; Guo J; Chen J; Guo B; Cao W; Jiang Q
Transl Res; 2023 Sep; 259():62-71. PubMed ID: 37121538
[TBL] [Abstract][Full Text] [Related]
6. METTL3 upregulates COPS5 expression in osteosarcoma in an m
Zhang C; Wan J; Liu Q; Long F; Wen Z; Liu Y
Exp Cell Res; 2022 Nov; 420(2):113353. PubMed ID: 36100071
[TBL] [Abstract][Full Text] [Related]
7. m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.
Ling Z; Chen L; Zhao J
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32266933
[TBL] [Abstract][Full Text] [Related]
8. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
Wei K; Gao Y; Wang B; Qu YX
Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
[TBL] [Abstract][Full Text] [Related]
9. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
[TBL] [Abstract][Full Text] [Related]
10. USP13 regulates HMGB1 stability and secretion through its deubiquitinase activity.
Shin J; Kim YH; Lee B; Chang JH; Choi HY; Lee H; Song KC; Kwak MS; Choi JE; Shin JS
Mol Med; 2022 Dec; 28(1):164. PubMed ID: 36585612
[TBL] [Abstract][Full Text] [Related]
11. Auto-ubiquitination of NEDD4-1 Recruits USP13 to Facilitate Autophagy through Deubiquitinating VPS34.
Xie W; Jin S; Wu Y; Xian H; Tian S; Liu DA; Guo Z; Cui J
Cell Rep; 2020 Feb; 30(8):2807-2819.e4. PubMed ID: 32101753
[TBL] [Abstract][Full Text] [Related]
12. Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.
Zhou L; Yang C; Zhang N; Zhang X; Zhao T; Yu J
Biomed Pharmacother; 2020 May; 125():109964. PubMed ID: 32044716
[TBL] [Abstract][Full Text] [Related]
13. METTL3-mediated m
Chen X; Gong W; Shao X; Shi T; Zhang L; Dong J; Shi Y; Shen S; Qin J; Jiang Q; Guo B
Ann Rheum Dis; 2022 Jan; 81(1):87-99. PubMed ID: 34706873
[TBL] [Abstract][Full Text] [Related]
14. Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy.
Gao J; Fang Y; Chen J; Tang Z; Tian M; Jiang X; Tao C; Huang R; Zhu G; Qu W; Wu X; Zhou J; Fan J; Liu W; Shi Y
Oncogene; 2023 Aug; 42(33):2507-2520. PubMed ID: 37420030
[TBL] [Abstract][Full Text] [Related]
15. METTL3/YTHDF2 m
Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L
J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149
[TBL] [Abstract][Full Text] [Related]
16. METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma.
Li HB; Huang G; Tu J; Lv DM; Jin QL; Chen JK; Zou YT; Lee DF; Shen JN; Xie XB
EBioMedicine; 2022 Aug; 82():104142. PubMed ID: 35810559
[TBL] [Abstract][Full Text] [Related]
17. m
Liu Y; Zhai E; Chen J; Qian Y; Zhao R; Ma Y; Liu J; Huang Z; Cai S; Chen J
Cancer Commun (Lond); 2022 Apr; 42(4):327-344. PubMed ID: 35261206
[TBL] [Abstract][Full Text] [Related]
18. The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer.
Morgan EL; Patterson MR; Barba-Moreno D; Scarth JA; Wilson A; Macdonald A
Oncogene; 2021 Mar; 40(11):2112-2129. PubMed ID: 33627786
[TBL] [Abstract][Full Text] [Related]
19. m
Wang X; Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Shi H; Wang F; Wang Y
Autophagy; 2020 Jul; 16(7):1221-1235. PubMed ID: 31451060
[TBL] [Abstract][Full Text] [Related]
20. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
